Elizabeth Garofalo

Dr. Elizabeth A. Garofalo, MD, is an Independent Director at Alector, Inc., an Independent Director at Xenon Pharmaceuticals, Inc., an Independent Director at ACADIA Pharmaceuticals, Inc. and a Principal at EAG Pharma Consulting LLC.
She is on the Board of Directors at Alector, Inc., Xenon Pharmaceuticals, Inc., ACADIA Pharmaceuticals, Inc. and Institute For Advanced Clinical Trials For Children.
Dr. Garofalo was previously employed as a Chairman by Exicure, Inc., a VP & Head-Neuroscience Therapy Area by Astellas Pharma Global Development, Inc., a Global Head-Clinical Development & Senior VP by Novartis International AG, and a Head-Neuroscience & Worldwide Regulatory Affairs by Pfizer Inc. She received her undergraduate degree from Purdue University and a doctorate degree from The Indiana University School of Medicine.